Decision on Coronavac vaccine at advanced stage, says medicines health regulator
The WHO has listed the Sinopharm vaccine produced by Beijing Bio-Institute of Biological Products, for emergency use
21 June 2021 - 17:59
The prospects for a wider access by SA to a variety of vaccines may be looking brighter as the health products regulator's review of the Chinese Coronavac vaccine is at a “very advanced stage” and it is also conducting a rolling review of the Russian Sputnik vaccine.
The SA Health Products Regulator (Saphra) has so far approved the Pfizer and the Johnson & Johnson vaccines. Both vaccines were used for the Sisonke programme to vaccinate health workers but the supply of J&J vaccines was held up as a result of their contamination at a US plant...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.